EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Trends Analyst Outlook Journalist POV
12.21 USD
+0.48
4.09%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
12.11
--0.10
0.82%
1 day
4.09%
5 days
4.09%
1 month
-14.26%
3 months
24.09%
6 months
79.03%
Year to date
52.05%
1 year
6.54%
5 years
226.47%
10 years
-68.2%
 

About: EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Employees: 144

Healthcare Biotechnology
0
Funds holding %
of 7,505 funds
Explore Fund Trends
0
Analysts bullish %
of 2 analysts
See Analyst Outlook
0
Positive news %
of 6 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™